South Korea Retinal Biologics Market Thumbnail Image

2023

South Korea Retinal Biologics Market

South Korea Retinal Biologics Market, by Drug Class (VEGF-A Antagonist, Others), by Indication (Macular Degeneration, Diabetic Retinopathy, Others), by Distribution Channel (Hospital Pharmacies, Drug Stores and Retail Pharmacies, Online Providers): Opportunity Analysis and Industry Forecast, 2022-2032

LS : Pharmaceuticals

  • Jul 2023

  • Pages: 86

  • Tables: 53

  • Charts: 49

Select an option
Cloud Access (30% Off) $2,175 $1,523
Business User License (30% Off) $3,255 $2,279
Enterprise License (30% Off) $5,055 $3,539
Library Membership (15% Off) $1,175 $999
Request Free Sample
Author's: Monika Darandale | Eswara Prasad
Publish Date:
Enquire Before Buying Update on Demand Speak with Analyst